Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
condarive sodium
- Development stage
- Unknown
- Lead developer
- Guangdong Dongyangguang Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Condarive sodium (HEC110114) is a small molecule direct-acting antiviral (DAA) developed by Guangdong Dongyangguang Pharmaceutical (HEC Pharm) for the treatment of chronic hepatitis C virus (HCV) infection. It functions as an inhibitor of the HCV NS3/4A protease, an enzyme essential for the processing of the viral polyprotein into functional units required for viral replication. In clinical studies, such as the Phase 1 trial CTR20171515, condarive sodium has been evaluated for its safety, tolerability, and pharmacokinetic properties in healthy subjects, including assessments of single and multiple ascending doses and food effects. It is typically investigated as a component of combination regimens aimed at achieving high sustained virologic response (SVR) rates across multiple HCV genotypes.
- Other names
- 康达瑞韦钠
02
Targets
NS3/4A (Hepatitis C virus nonstructural protein 3/4A serine protease)
Beyond the preview
Go deeper on condarive sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on condarive sodium.